Hong Kong’s ban on cannabidiol (CBD) comes into effect on February 1, imposing harsh penalties for importing, producing, or possessing the substance.
CBD will be subject to the same strict controls as other drugs listed under the Dangerous Drugs Ordinance (DDO).
The importation of goods containing the component, including food and beverages, is forbidden, according to Hong Kong's customs administration, unless pertinent DDO rules are followed.
Au-Yeung Ka-lun, a customs intelligence officer, stated that CBD will be treated as a dangerous narcotic and will be governed by the Dangerous Drugs Ordinance.
The maximum punishment for importing, exporting, and producing CBD is a HKD 5 million fine and a life sentence. The maximum penalty for possession is seven years in prison and a fine of up to HKD 1 million.
By the end of the month, all items containing the component were to be put in trash boxes erected throughout the city, according to a government directive. Approximately 77,400 CBD-containing products, including dietary supplements and edible oils, have been gathered as of January 29.


RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow
Wall Street Ends Mixed as Micron Surges, Apple Drops After Price Hikes
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test
SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices
Wall Street Ends Lower as AI Stocks Drag Markets, Fed Rate Outlook Shifts
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence
ICC Judges Sue Trump Administration Over Sanctions, Calling Measures Unlawful
Gold Prices Rise Above $4,000 as Inflation Data and Weaker Dollar Boost Demand
South Korea’s KOSPI Plunges as Apple Price Hikes and OpenAI IPO Delay Shake AI Chip Stocks
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access 



